BackBurning Rock Biotech Overview

Burning Rock Biotech Intangible Assets

Latest intangible assets for BNR: $260K.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$257030.00

Peer average

Loading

Burning Rock Biotech Intangible Assets History

Loading

Burning Rock Biotech vs. peers: Intangible Assets Comparison

Loading

Burning Rock Biotech Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Burning Rock Biotech (BNR) FAQ

Burning Rock Biotech (BNR) currently reports a intangible assets of $260K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Burning Rock Biotech's intangible assets history and peer comparisons.

Burning Rock Biotech's intangible assets changed from $0 to $260K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Burning Rock Biotech reported $260K in intangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $260K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Burning Rock Biotech, and consider following BNR for alerts when major investors trade the stock.

Burning Rock Biotech is classified in the Healthcare sector. On intangible assets, it currently shows $260K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNR with unrelated industries.